Literature DB >> 9566786

Mapping epitopes for 20 monoclonal antibodies to CR1.

M Nickells1, R Hauhart, M Krych, V B Subramanian, K Geoghegan-Barek, H C Marsh, J P Atkinson.   

Abstract

Complement receptor type one (CR1; CD35) binds and processes C3b and C4b opsonized immune complexes and regulates complement activation. We have characterized the epitopes of 13 previously reported and seven new MoAbs to human CR1. The MoAbs formed seven groups based on their reactivity with a panel of deletion forms of CR1. Seventeen of the MoAbs reacted with CR1 at more than one site, a consequence of its repetitive sequence. All five of the MoAbs recognizing epitopes in the nearly identical repeats 3, 10, and 17, as well as one MoAb which reacted with repeats 8 or 1/2 of 9 and 15 or 1/2 of 16, blocked cofactor activity for C3b. Knowledge of the repeats bearing the epitopes for these MoAbs should facilitate the further characterization of CR1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566786      PMCID: PMC1904933          DOI: 10.1046/j.1365-2249.1998.00549.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Mouse monoclonal antibodies to the human C3b receptor.

Authors:  J Cook; E Fischer; C Boucheix; M Mirsrahi; M H Jouvin; L Weiss; R M Jack; M D Kazatchkine
Journal:  Mol Immunol       Date:  1985-05       Impact factor: 4.407

2.  A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.

Authors:  S M Scesney; S C Makrides; M L Gosselin; P J Ford; B M Andrews; E G Hayman; H C Marsh
Journal:  Eur J Immunol       Date:  1996-08       Impact factor: 5.532

3.  Human complement (C3b) receptors defined by a mouse monoclonal antibody.

Authors:  J Gerdes; M Naiem; D Y Mason; H Stein
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

4.  Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1).

Authors:  N Hogg; G D Ross; D B Jones; M Slusarenko; M J Walport; P J Lachmann
Journal:  Eur J Immunol       Date:  1984-03       Impact factor: 5.532

5.  Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.

Authors:  J J O'Shea; E J Brown; B E Seligmann; J A Metcalf; M M Frank; J I Gallin
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

6.  PMA induces the ligand-independent internalization of CR1 on human neutrophils.

Authors:  P S Changelian; R M Jack; L A Collins; D T Fearon
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.

Authors:  F A Tausk; A McCutchan; P Spechko; R D Schreiber; I Gigli
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Erythrocyte CR1 determination using monoclonal antibody in a microtiter plate ELISA; receptors are not masked by immune complexes.

Authors:  B S Thomsen; H Nielsen; G Bendixen
Journal:  Allergy       Date:  1986-09       Impact factor: 13.146

9.  Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.

Authors:  L B Klickstein; W W Wong; J A Smith; J H Weis; J G Wilson; D T Fearon
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

10.  Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.

Authors:  D Hourcade; D R Miesner; J P Atkinson; V M Holers
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  25 in total

1.  A new assay to monitor the degranulation process in phagocytizing human neutrophils.

Authors:  Violetta Borelli; Maria Giovanna Perrotta; Francesca Vita; Maria Rosa Soranzo; Giuliano Zabucchi
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

2.  CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process.

Authors:  Mark I Melhorn; Abigail S Brodsky; Jessica Estanislau; Joseph A Khoory; Ben Illigens; Itaru Hamachi; Yasutaka Kurishita; Andrew D Fraser; Anne Nicholson-Weller; Elena Dolmatova; Heather S Duffy; Ionita C Ghiran
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

3.  Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.

Authors:  Jenny U Johansson; William D Brubaker; Harold Javitz; Andrew W Bergen; Denise Nishita; Abhishek Trigunaite; Andrés Crane; Justine Ceballos; Diego Mastroeni; Andrea J Tenner; Marwan Sabbagh; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2018-05-21       Impact factor: 21.566

Review 4.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

5.  Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.

Authors:  Sergei Zaitsev; Kristina Danielyan; Juan-Carlos Murciano; Kumkum Ganguly; Tatiana Krasik; Ronald P Taylor; Steven Pincus; Steven Jones; Douglas B Cines; Vladimir R Muzykantov
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

6.  Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.

Authors:  Boudewijn Klop; Pieter van der Pol; Robin van Bruggen; Yanan Wang; Marijke A de Vries; Selvetta van Santen; Joseph O'Flynn; Gert-Jan M van de Geijn; Tjin L Njo; Hans W Janssen; Peter de Man; J Wouter Jukema; Ton J Rabelink; Patrick C N Rensen; Cees van Kooten; Manuel Castro Cabezas
Journal:  J Biol Chem       Date:  2014-10-27       Impact factor: 5.157

7.  A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).

Authors:  A Repik; S E Pincus; I Ghiran; A Nicholson-Weller; D R Asher; A M Cerny; L S Casey; S M Jones; S N Jones; N Mohamed; L B Klickstein; G Spitalny; R W Finberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

8.  Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum.

Authors:  Carmenza Spadafora; Gordon A Awandare; Karen M Kopydlowski; Jozsef Czege; J Kathleen Moch; Robert W Finberg; George C Tsokos; José A Stoute
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

9.  Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).

Authors:  C-H Chen; I Ghiran; F J M Beurskens; G Weaver; J A Vincent; A Nicholson-Weller; L B Klickstein
Journal:  Clin Exp Immunol       Date:  2007-06       Impact factor: 4.330

Review 10.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.